![Express Pharma Magazine - February 2025 Express Pharma Magazine Cover - February 2025 Edition](https://files.magzter.com/resize/magazine/1394808148/1738479328/view/1.jpg)
![Gold Icon](/static/images/goldicons/gold-sm.png)
Express Pharma Magazine - February 2025![Add to My Favorites Add to Favorites](/static/icons/filled.svg)
![](/static/icons/sharenew.svg)
Go Unlimited with Magzter GOLD
Read Express Pharma along with 9,000+ other magazines & newspapers with just one subscription View catalog
1 Month $9.99
1 Year$99.99 $49.99
$4/month
Subscribe only to Express Pharma
1 Year $5.49
Save 54%
Buy this issue $0.99
In this issue
India's Foremost Pharma & Biotech Magazine ~ Decoding the M&A Landscape
Our vision is to make cutting-edge therapies accessible to Indian patients
Amit Mookim, CEO, Immuneel Therapeutics, discusses the launch of Qartemi, India's first CAR T-cell therapy, and the company's vision to make advanced cell and gene therapies accessible and affordable for Indian patients.
![Our vision is to make cutting-edge therapies accessible to Indian patients Our vision is to make cutting-edge therapies accessible to Indian patients](https://reseuro.magzter.com/100x125/articles/5843/1981257/NeJDm3ZX11738579603906/OUR-VISION-IS-TO-MAKE-CUTTINGEDGE-THERAPIES-ACCESSIBLE-TO-INDIAN-PATIENTS.jpg)
3 mins
The group's offerings range from over a billion injection doses annually to bespoke medical machinery
Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.
![The group's offerings range from over a billion injection doses annually to bespoke medical machinery The group's offerings range from over a billion injection doses annually to bespoke medical machinery](https://reseuro.magzter.com/100x125/articles/5843/1981257/ytLU7DSi51738579961377/THE-GROUPS-OFFERINGS-RANGE-FROM-OVER-A-BILLION-INJECTION-DOSES-ANNUALLY-TO-BESPOKE-MEDICAL-MACHINERY.jpg)
4 mins
DECODING THE M&A LANDSCAPE
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.
![DECODING THE M&A LANDSCAPE DECODING THE M&A LANDSCAPE](https://reseuro.magzter.com/100x125/articles/5843/1981257/m9-U1Nic21738580242970/DECODING-THE-MA-LANDSCAPE.jpg)
8 mins
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.
![Evolution and commercialisation of cell and gene therapies Evolution and commercialisation of cell and gene therapies](https://reseuro.magzter.com/100x125/articles/5843/1981257/6TatCW-851738582670742/EVOLUTION-AND-COMMERCIALISATION-OF-CELL-AND-GENE-THERAPIES.jpg)
6 mins
The unmissable Asia healthcare opportunity
BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.
![The unmissable Asia healthcare opportunity The unmissable Asia healthcare opportunity](https://reseuro.magzter.com/100x125/articles/5843/1981257/FkJMEHrta1738583001800/THE-UNMISSABLE-ASIA-HEALTHCARE-OPPORTUNITY.jpg)
10+ mins
Pharma's strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.
![Pharma's strategic path to growth in the nutra maze Pharma's strategic path to growth in the nutra maze](https://reseuro.magzter.com/100x125/articles/5843/1981257/S7RL7urj51738585009245/PHARMAS-STRATEGIC-PATH-TO-GROWTH-IN-THE-NUTRA-MAZE.jpg)
6 mins
2025: Healthcare and Lifesciences investment outlook
Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year
![2025: Healthcare and Lifesciences investment outlook 2025: Healthcare and Lifesciences investment outlook](https://reseuro.magzter.com/100x125/articles/5843/1981257/gni4wTlSk1738585367741/2025-HEALTHCARE-AND-LIFESCIENCES-INVESTMENT-OUTLOOK.jpg)
8 mins
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
![PROSOLV® 730: Directly compressible carrier for lipophilic ingredients PROSOLV® 730: Directly compressible carrier for lipophilic ingredients](https://reseuro.magzter.com/100x125/articles/5843/1981257/6cppB9bi11738586297726/PROSOLV-730-DIRECTLY-COMPRESSIBLE-CARRIER-FOR-LIPOPHILIC-INGREDIENTS.jpg)
3 mins
AI smart camera for real-time automation
Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low
![AI smart camera for real-time automation AI smart camera for real-time automation](https://reseuro.magzter.com/100x125/articles/5843/1981257/s351jeUlb1738587298023/AI-SMART-CAMERA-FOR-REALTIME-AUTOMATION.jpg)
1 min
PRIME NEO from Gandhi Automations
Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable
![PRIME NEO from Gandhi Automations PRIME NEO from Gandhi Automations](https://reseuro.magzter.com/100x125/articles/5843/1981257/pSoWQPTC11738587385901/PRIME-NEO-FROM-GANDHI-AUTOMATIONS.jpg)
1 min
Express Pharma Magazine Description:
Publisher: The Indian Express Ltd.
Category: Health
Language: English
Frequency: Monthly
Express Pharma formerly Express Pharma Pulse, one of the most widely read publication in pharmaceutical media since 1994, published by one of the oldest and most respected media group in India, the Indian Express Group. Express Pharma is India’s foremost Pharma & Biotech publication, published in a handy size and an international format, designed for readers convenience. Organized into four sections – Market, Management, Research and Pharma Life, it caters to the information needs of all levels of the pharmaceutical and biotech professionals. EP offers the widest geographic reach, focused business segment coverage and the sure means to reach the senior management and decision makers across the Industry.
Cancel Anytime [ No Commitments ]
Digital Only